(2E)-1-(3-chlorophenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

(1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid, 95.0%, 1g

(2S,5R,6R)-6-((S)-2-Amino-2-(4-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (Amoxicillin Impurity), 97%, 25mg

OCTENIDINE DIHYDROCHLORIDE, 95%, 5g

(E)-3-(4-((1H-Imidazol-1-yl)methyl)phenyl)acrylic acid hydrochloride, 95.0%, 1g

4-(Pyridin-4-yl)benzonitrile, 95%, 250mg

Methyl 2-amino-4-chloro-5-iodobenzoate, 95.0%, 25g

Adamantane-1,3-diamine, 98+%, 25g

N-(4-Bromo-2,6-dimethylphenyl)acetamide, 95.0%, 1g

1-(propan-2-yl)-1H-indole-2-carboxylic acid, >95%, 1g

2-(3-Methylcyclohexyl)acetic acid, 95.0%, 250mg

Closing caps SILICOSEN®, C-30, Gesch. front, 18-30 mm 10 pcs

Tert-butyl 4-cyano-4-(p-tolyl)piperidine-1-carboxylate, 98%, 250mg